Luliconazole
Azole Antifungal — DERMATOLOGICALS
Also known as: lulicon, luzu, NND-502, PR-2699
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Luliconazole is an onp drug in the Azole Antifungal class catalogued in DrugCentral. It was first approved by the FDA in 2013. Its mechanism of action is classified as Cytochrome P450 2C19 Inhibitors. DrugCentral lists 1 molecular target, including ERG11. Recorded indications include Tinea corporis, Tinea cruris and Tinea pedis.
- Approval status: onp (first approved 2013 by the FDA).
- Drug class: Azole Antifungal.
- Mechanism of action: Cytochrome P450 2C19 Inhibitors.
- Molecular targets: ERG11 (1 listed in DrugCentral).
- Indications: Tinea corporis, Tinea cruris and Tinea pedis.
- ATC code: D01AC18 (Imidazole and triazole derivatives).
- Molecular formula: C14H9Cl2N3S2; molecular weight 354.27 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (3)
- Tinea corporis
- Tinea cruris
- Tinea pedis
Mechanism & targets
| Mechanism of action (MoA) | Cytochrome P450 2C19 Inhibitors |
|---|---|
| Established pharmacologic class | Azole Antifungal |
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Lanosterol 14-alpha demethylase | ERG11 | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2013-11-14 | FDA | — | MEDICIS |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
D01AC18 | DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Imidazole and triazole derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Luliconazole is on its molecule page.
| Molecular formula | C14H9Cl2N3S2 |
|---|---|
| Molecular weight | 354.27 g/mol |
| CAS number | 187164-19-8 |
| InChIKey | YTAOBBFIOAEMLL-REQDGWNSSA-N |
| PubChem CID | 3003141 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Luliconazole used for?
DrugCentral lists the following indications for Luliconazole: Tinea corporis, Tinea cruris and Tinea pedis.
How does Luliconazole work?
Luliconazole is classified as Cytochrome P450 2C19 Inhibitors; its molecular targets in DrugCentral include ERG11 (inhibitor).
When was Luliconazole first approved?
Luliconazole was first approved by the FDA in 2013.
What drug class does Luliconazole belong to?
Luliconazole is in the Azole Antifungal class.
What is the chemical formula of Luliconazole?
Luliconazole has the molecular formula C14H9Cl2N3S2 and a molecular weight of 354.27 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4813 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2105689 — compound record and bioactivity
- PubChem CID 3003141 — chemical identifiers
- DrugBank DB08933 — drug record
- FDA UNII RE91AN4S8G — substance identity
- DailyMed: FDA labels for Luliconazole — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.